Horn Howard Insider Trading Activity
Horn Howard has been net-selling over the last 12 months with 0 purchases and 10 sales across 1 company.
RARE is the most-traded position with 10 trades. The largest single transaction was a sale of RARE for $121K on Mar 2, 2026.
Performance Scorecard
Forward stock performance after each transaction by Horn Howard. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +2.5% | 50% | 10 |
| 90 days | — | -1.2% | 33% | 9 |
| 120 days | — | -12.0% | 33% | 9 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersRARE · Ultragenyx Pharmaceutical Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Horn Howard bought and sold RARE.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Oct 15, 2026 | RARE | Sell | 7,066 | $15.27 | $108K | −7.3% | CFO | |
Aug 3, 2026 | RARE | Sell | 4,696 | $24.92 | $117K | −4.6% | CFO | |
May 1, 2026 | RARE | Sell | 4,683 | $24.90 | $117K | −4.1% | CFO | |
Apr 1, 2026 | RARE | Sell | 4,683 | $20.97 | $98K | −5.5% | CFO | |
Mar 3, 2026 | RARE | Sell | 1,635 | $22.40 | $37K | −1.9% | CFO | |
Mar 2, 2026 | RARE | Sell | 5,290 | $22.80 | $121K | −5.6% | CFO | |
Mar 2, 2026 | RARE | Sell | 3,119 | $22.54 | $70K | −3.5% | CFO | |
Feb 2, 2026 | RARE | Sell | 3,061 | $23.56 | $72K | −3.3% | CFO | |
Jan 2, 2026 | RARE | Sell | 3,150 | $22.84 | $72K | −3.3% | CFO | |
Dec 10, 2025 | RARE | Sell | 3,081 | $36.38 | $112K | −3.1% | CFO | |
Oct 13, 2025 | RARE | Sell | 7,942 | $31.51 | $250K | −7.5% | CFO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | 11 | $1.2M |
Other insiders at Ultragenyx Pharmaceutical Inc.
2 other tracked filers at RARE.